HealthQuill Health
The East African nation of Kenya confirmed its first case of Ebola after one of its citizens who flew into the capital, Nairobi, died of the disease.
Drugs Health Medical

Kenya confirms first confirmed case of Ebola virus, citizen came from Congo

The East African nation of Kenya confirmed its first case of Ebola after one of its citizens who flew into the capital, Nairobi,.

Read More
New York Governor Kathy Hochul declared a state of emergency in the most populous city in the United States over a measles outbreak.
Drugs Health Medical

New York State issues emergency order to fight measles surge

New York Governor Kathy Hochul declared a state of emergency in the most populous city in the United States over a measles outbreak.

Read More
Non-communicable diseases (NCDs) accounted for eight of the world’s ten leading causes of death in 2023, up from 58% in 2000, according to a report by the World Health Organization.
Drugs Health Medical

Non-communicable diseases account for 74% of global deaths: WHO

HQ Team October 5, 2026:  Non-communicable diseases (NCDs) accounted for eight of the world’s ten leading causes of death in 2023, up from.

Read More
China’s Abogen Biosciences has signed a $7.8 billion licensing and option pact with Novartis AG to make messenger RNA-encoded therapies, which have the potential to treat autoimmune diseases in a more advanced form than the existing ones.
Drugs Health Pharma

Novartis inks $7.8b deal with China’s Abogen for mRNA trial therapy

HQ Team October 4, 2026: China’s Abogen Biosciences has signed a $7.8 billion licensing and option pact with Novartis AG to make messenger.

Read More
The USFDA has approved GSK Plc’s oral therapy to treat anaemia in patients with myelofibrosis, a type of bone cancer.
Health

Engineered marrow cells cut fractures in osteoporosis patients in tiny trial

HQ Team September 24, 2026: Osteoporosis, a disease that thins bones and makes patients vulnerable to fractures at the slightest falls. This progressive.

Read More
The human brain didn’t evolve as one single unit, but as two distinct organs independently, Stanford researchers found — a discovery that holds promise to fight brain stem diseases such as spinal muscular atrophy and amyotrophic lateral sclerosis.
Health Medical Research

Human brain is not a single unit,  they are two: Stanford researchers find

HQ Team September 23, 2026: The human brain didn’t evolve as one single unit, but as two distinct organs independently, Stanford researchers found.

Read More
Novo Nordisk A/S or Novo, has partnered with UNICEF to expand their global partnership for four years to fight childhood overweight and obesity, and the Danish company has committed $18 million until 2030.
Drugs Health Medical

Novo-UNICEF extends pact to fight child obesity, Novo to pump in $18m

HQ Team September 23, 2026: Novo Nordisk A/S or Novo, has partnered with UNICEF to expand their global partnership for four years to.

Read More
The European Commission has approved AbbVie Inc.’s drug for the treatment of active polyarticular juvenile idiopathic arthritis in patients two years of age and older who have responded inadequately to, or who are intolerant to, one or more disease-modifying anti-rheumatic drugs.
Drugs Health Pharma

EC approves AbbVie Inc.s drug for a type of juvenile idiopathic arthritis

HQ Team September 22, 2026: The European Commission has approved AbbVie Inc.’s drug for the treatment of active polyarticular juvenile idiopathic arthritis in.

Read More
Danish drugmaker Novo Nordisk’s investigational drug, CagriSema, has achieved an estimated average weight loss of 12.4% in diabetic patients during an end-stage trial, better than rival Eli Lilly’s drug.
Health Pharma Research

Novo Nordisk’s test drug outperforms rival Lilly’s in diabetic patients

HQ Team September 21, 2026: Danish drugmaker Novo Nordisk’s investigational drug, CagriSema, has achieved an estimated average weight loss of 12.4% in diabetic.

Read More
The US Food and Drug Administration has approved a combination oral drug from Eli Lilly and Company to treat people with a type of breast cancer that has worsened after at least one hormone treatment.The US Food and Drug Administration has approved a combination oral drug from Eli Lilly and Company to treat people with a type of breast cancer that has worsened after at least one hormone treatment.
Drugs Health Pharma

FDA clears Eli Lilly’s combination drug for metastatic breast cancer

HQ Team September 21, 2026: The US Food and Drug Administration has approved a combination oral drug from Eli Lilly and Company to.

Read More